Abbott's Nutrition segment reported a 3.1% sales decline in the second quarter, with comparable sales down 3.6%. The company attributes the drop to lower sales volumes compared to the prior year and strategic pricing actions implemented in the fourth quarter of 2025. U.S. Pediatric Nutrition fell 10.7%, while international pediatric sales rose 7.3%. There's a sequential uptick, however: Nutrition sales increased $127 million from the first quarter of 2026. Abbott says the pricing actions and new product launches are contributing to improving performance
This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors.
(END) Dow Jones Newswires
July 16, 2026 08:19 ET (12:19 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.